Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity

Mutations in SCN1A gene, encoding the voltage-gated sodium channel (VGSC) NaV1.1, are widely recognized as a leading cause of genetic febrile seizures (FS), due to the decrease in the Na+ current density, mainly affecting the inhibitory neuronal transmission. Here, we generated induced pluripotent stem cells (iPSCs)-derived neurons (idNs) from a patient belonging to a genetically well-characterized Italian family, carrying the c.434T > C mutation in SCN1A gene (hereafter SCN1AM145T). A side-by-side comparison of diseased and healthy idNs revealed an overall maturation delay of SCN1AM145T cells. Membranes isolated from both diseased and control idNs were injected into Xenopus oocytes and both GABA and AMPA currents were successfully recorded. Patch-clamp measurements on idNs revealed depolarized action potential for SCN1AM145T, suggesting a reduced excitability. Expression analyses of VGSCs and chloride co-transporters NKCC1 and KCC2 showed a cellular “dysmaturity” of mutated idNs, strengthened by the high expression of SCN3A, a more fetal-like VGSC isoform, and a high NKCC1/KCC2 ratio, in mutated cells. Overall, we provide strong evidence for an intrinsic cellular immaturity, underscoring the role of mutant NaV1.1 in the development of FS. Furthermore, our data are strengthening previous findings obtained using transfected cells and recordings on human slices, demonstrating that diseased idNs represent a powerful tool for personalized therapy and ex vivo drug screening for human epileptic disorders.

[1]  S. Baxendale.  The cognitive costs, contraindications and complications of epilepsy surgery in adults. , 2020, Current opinion in neurology.

[2]  G. Perozziello,et al.  A Disposable Passive Microfluidic Device for Cell Culturing , 2020, Biosensors.

[3]  H. Ng,et al.  Direct Induction and Functional Maturation of Forebrain GABAergic Neurons from Human Pluripotent Stem Cells. , 2016, Cell reports.

[4]  D. Sinnecker,et al.  Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets , 2015, PloS one.

[5]  R. Dolmetsch,et al.  A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients , 2016, eLife.

[6]  A. Ramasamy,et al.  Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A , 2013, Brain : a journal of neurology.

[7]  C. D. De Zeeuw,et al.  Chloride Homeostasis in Neurons With Special Emphasis on the Olivocerebellar System: Differential Roles for Transporters and Channels , 2018, Front. Cell. Neurosci..

[8]  P. Camfield,et al.  Incidence, prevalence and aetiology of seizures and epilepsy in children. , 2015, Epileptic disorders : international epilepsy journal with videotape.

[9]  S. Franceschetti,et al.  Electroclinical Features of a Family with Simple Febrile Seizures and Temporal Lobe Epilepsy Associated with SCN1A Loss‐of‐Function Mutation , 2007, Epilepsia.

[10]  A. L. Goldin,et al.  Early-life febrile seizures worsen adult phenotypes in Scn1a mutants , 2017, Experimental Neurology.

[11]  Massimo Mantegazza,et al.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy , 2006, Nature Neuroscience.

[12]  Claudio Rivera,et al.  Cation-Chloride Cotransporters and Neuronal Function , 2009, Neuron.

[13]  Dieter Schmidt,et al.  New avenues for anti-epileptic drug discovery and development , 2013, Nature Reviews Drug Discovery.

[14]  E. Palma,et al.  Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsy , 2013, Front. Cell. Neurosci..

[15]  P. Emson,et al.  Comparative distribution of voltage-gated sodium channel proteins in human brain. , 2001, Brain research. Molecular brain research.

[16]  J. F. Kerrigan,et al.  Functional rundown of gamma‐aminobutyric acidA receptors in human hypothalamic hamartomas , 2011, Annals of neurology.

[17]  Maria K. Lehtinen,et al.  Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development , 2018, Neuron.

[18]  D. O'Dowd,et al.  Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS+ , 2021, eNeuro.

[19]  C. Limatola,et al.  A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy , 2018, Neurobiology of Disease.

[20]  C. Reid,et al.  Sodium channel expression and transcript variation in the developing brain of human, Rhesus monkey, and mouse , 2022, Neurobiology of Disease.

[21]  M. Marín-Gracia,et al.  Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies , 2022, Biomedicines.

[22]  E. Musto,et al.  Recent advances in treatment of epilepsy-related sodium channelopathies. , 2019, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[23]  O. Brüstle,et al.  A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration , 2009, Proceedings of the National Academy of Sciences.

[24]  Y. Ben-Ari,et al.  The GABA excitatory/inhibitory developmental sequence: A personal journey , 2014, Neuroscience.

[25]  N. Rezaei,et al.  Genetic background of febrile seizures , 2014, Reviews in the neurosciences.

[26]  J. A. Payne,et al.  Cation-chloride cotransporters in neuronal development, plasticity and disease , 2014, Nature Reviews Neuroscience.

[27]  J. Rubenstein,et al.  Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome , 2012, Proceedings of the National Academy of Sciences.

[28]  I. Scheffer,et al.  Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? , 2009, Brain and Development.

[29]  J. Lekkala,et al.  A modular brain-on-a-chip for modelling epileptic seizures with functionally connected human neuronal networks. , 2020, Biosensors & bioelectronics.

[30]  Jerome Engel,et al.  The current place of epilepsy surgery , 2017, Current opinion in neurology.

[31]  C. Wierenga,et al.  Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions , 2018, Neuroscience & Biobehavioral Reviews.

[32]  G. Cuda,et al.  Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus , 2019, Journal of cellular and molecular medicine.

[33]  Asla Pitkänen,et al.  Advances in the development of biomarkers for epilepsy , 2016, The Lancet Neurology.

[34]  I. Scheffer,et al.  The genetics of Dravet syndrome , 2011, Epilepsia.

[35]  F Giangaspero,et al.  Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. L. Goldin,et al.  A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation , 2009, Neurobiology of Disease.

[37]  A. Heils,et al.  A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy. , 2001, American journal of human genetics.

[38]  E. Aronica,et al.  Dissecting the Molecular Determinants of GABAA Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy , 2021, Brain sciences.

[39]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[40]  T. Serikawa,et al.  A Missense Mutation of the Gene Encoding Voltage-Dependent Sodium Channel (Nav1.1) Confers Susceptibility to Febrile Seizures in Rats , 2010, The Journal of Neuroscience.

[41]  H. Beck,et al.  Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation , 2014, The Journal of Neuroscience.

[42]  E. Aronica,et al.  Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives. , 2016, Pharmacological research.

[43]  A. Contestabile,et al.  Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome , 2015, Nature Medicine.

[44]  K. Nabeshima,et al.  A human Dravet syndrome model from patient induced pluripotent stem cells , 2013, Molecular Brain.

[45]  G. Cuda,et al.  Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease. , 2021, Stem cell research.

[46]  E. Bartolini,et al.  Epilepsy and brain channelopathies from infancy to adulthood , 2019, Neurological Sciences.

[47]  I. Scheffer,et al.  SCN1A‐related phenotypes: Epilepsy and beyond , 2019, Epilepsia.

[48]  F. Gage,et al.  KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome , 2016, Proceedings of the National Academy of Sciences.

[49]  R. Miledi,et al.  GABAA-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABAA “phasic” receptors , 2007, Proceedings of the National Academy of Sciences.

[50]  C. Limatola,et al.  A novel GABAergic dysfunction in human Dravet syndrome , 2018, Epilepsia.

[51]  C. Limatola,et al.  Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions , 2016, Neurobiology of Disease.

[52]  J. Parent,et al.  Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. , 2020, Brain : a journal of neurology.

[53]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[54]  L. Isom,et al.  Untangling the Dravet Syndrome Seizure Network: The Changing Face of a Rare Genetic Epilepsy , 2014, Epilepsy currents.

[55]  C. Limatola,et al.  Modulation of GABAergic dysfunction due to SCN1A mutation linked to Hippocampal Sclerosis , 2020, Annals of clinical and translational neurology.

[56]  G. Perozziello,et al.  A Passive Microfluidic Device for Chemotaxis Studies , 2019, Micromachines.

[57]  W. Löscher.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs , 2017, Neurochemical Research.

[58]  William M. Stern,et al.  Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome , 2017, Neurology.

[59]  G. Cuda,et al.  Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene. , 2020, Stem cell research.

[60]  John S Duncan,et al.  The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study , 2011, The Lancet.

[61]  Amandine Duflocq,et al.  Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments , 2008, Molecular and Cellular Neuroscience.

[62]  Clive N Svendsen,et al.  Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications. , 2019, Cell stem cell.

[63]  Robert C. Thompson,et al.  The More, the Better: Modeling Dravet Syndrome With Induced Pluripotent Stem Cell-Derived Neurons , 2014 .

[64]  G. Cuda,et al.  Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells , 2019, Journal of cellular and molecular medicine.

[65]  Aldo Quattrone,et al.  Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Miledi,et al.  Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Miledi,et al.  Enhancement of GABAA-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy , 2010, Proceedings of the National Academy of Sciences.

[68]  G. Cuda,et al.  Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine , 2019, International journal of molecular sciences.